Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 346 AL 360

Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease

Vijayan DK, Zhang KYJ.

Pharmacol Res. 2019 Sep;147:104342. doi: 10.1016/j.phrs.2019.104342. Epub 2019 Jul 6.

The search for meaning in preclinical Alzheimer disease clinical trials

Han SD, Shinotoh H.

Neurology. 2019 Jul 23;93(4):139-140. doi: 10.1212/WNL.0000000000007817. Epub 2019 Jul 9.

Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease

Veening-Griffioen DH, Ferreira GS, van Meer PJK, Boon WPC, Gispen-de Wied CC, Moors EHM, Schellekens H.

Eur J Pharmacol. 2019 Sep 15;859:172524. doi: 10.1016/j.ejphar.2019.172524. Epub 2019 Jul 7.

Distal Consequences of Oral Inflammation

Konkel JE, O'Boyle C, Krishnan S.

Front Immunol. 2019 Jun 25;10:1403. doi: 10.3389/fimmu.2019.01403. eCollection 2019.

The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer's Disease

Sánchez-Muniz FJ, Macho-González A, Garcimartín A, Santos-López JA, Benedí J, Bastida S, González-Muñoz MJ.

Nutrients. 2019 Jul 10;11(7):1558. doi: 10.3390/nu11071558.

Cu(II) Binding Properties of N-Truncated Aβ Peptides: In Search of Biological Function

Stefaniak E, Bal W.

Inorg Chem. 2019 Oct 21;58(20):13561-13577. doi: 10.1021/acs.inorgchem.9b01399. Epub 2019 Jul 15.

Advancements in nanotherapeutics for Alzheimer's disease: current perspectives

Harilal S, Jose J, Parambi DGT, Kumar R, Mathew GE, Uddin MS, Kim H, Mathew B.

J Pharm Pharmacol. 2019 Sep;71(9):1370-1383. doi: 10.1111/jphp.13132. Epub 2019 Jul 15.

Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease

Parodi-Rullán R, Sone JY, Fossati S.

J Alzheimers Dis. 2019;72(4):1019-1039. doi: 10.3233/JAD-190357.

Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review

Silva GM, Barcelos MP, Poiani JGC, Hage-Melim LIDS, da Silva CHTP.

ChemMedChem. 2019 Aug 20;14(16):1467-1483. doi: 10.1002/cmdc.201900299. Epub 2019 Aug 1.

Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential

Angelopoulou E, Piperi C.

Neuromolecular Med. 2019 Sep;21(3):227-238. doi: 10.1007/s12017-019-08558-2. Epub 2019 Jul 16.

Mitochondrial Dysfunctions: A Thread Sewing Together Alzheimer's Disease, Diabetes, and Obesity

Rigotto G, Basso E.

Oxid Med Cell Longev. 2019 Jun 16;2019:7210892. doi: 10.1155/2019/7210892. eCollection 2019.

The Role of Eicosanoids in Alzheimer's Disease

Biringer RG.

Int J Environ Res Public Health. 2019 Jul 18;16(14):2560. doi: 10.3390/ijerph16142560.

Structure and Function of Alzheimer's Amyloid βeta Proteins from Monomer to Fibrils: A Mini Review

Agrawal N, Skelton AA.

Protein J. 2019 Aug;38(4):425-434. doi: 10.1007/s10930-019-09854-3.

Diabetes drugs in the fight against Alzheimer's disease

Boccardi V, Murasecco I, Mecocci P.

Ageing Res Rev. 2019 Sep;54:100936. doi: 10.1016/j.arr.2019.100936. Epub 2019 Jul 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias